| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5629813 | Journal of Clinical Neuroscience | 2017 | 5 Pages |
Abstract
â¢Modality-specific outcomes of SRS and FSRT for benign meningiomas are unclear.â¢Significant differences in tumor regression rates between SRS and FSRT were found.â¢No difference in survival, local control and complication rate between SRS and FSRT.â¢SRS and FSRT are likely comparable treatments for benign intracranial meningioma.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Lawrance K. Chung, Ishani Mathur, Carlito Lagman, Timothy T. Bui, Seung J. Lee, Brittany L. Voth, Cheng Hao Jacky Chen, Natalie E. Barnette, Marko Spasic, Nader Pouratian, Percy Lee, Michael Selch, Robert Chin, Tania Kaprealian, Quinton Gopen,